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A B S T R A C T
The association of WW domain-containing oxidoreductase WWOX gene loss of function with central nervous
system (CNS) related pathologies is well documented. These include spinocerebellar ataxia, epilepsy and mental
retardation (SCAR12, OMIM: 614322) and early infantile epileptic encephalopathy (EIEE28, OMIM: 616211)
syndromes. However, there is complete lack of understanding of the pathophysiological mechanisms at play. In
this study, using a Wwox knockout (Wwox KO) mouse model (2 weeks old, both sexes) and stereological studies
we observe that Wwox deletion leads to a significant reduction in the number of hippocampal GABA-ergic (γ-
aminobutyric acid) interneurons. Wwox KO mice displayed significantly reduced numbers of calcium-binding
protein parvalbumin (PV) and neuropeptide Y (NPY) expressing interneurons in different subfields of the hip-
pocampus in comparison to Wwox wild-type (WT) mice. We also detected decreased levels of Glutamic Acid
Decarboxylase protein isoforms GAD65/67 expression in Wwox null hippocampi suggesting lower levels of
GABA synthesis. In addition, Wwox deficiency was associated with signs of neuroinflammation such as evidence
of activated microglia, astrogliosis, and overexpression of inflammatory cytokines Tnf-a and Il6. We also per-
formed comparative transcriptome-wide expression analyses of neural stem cells grown as neurospheres from
hippocampi of Wwox KO and WT mice thus identifying 283 genes significantly dysregulated in their expression.
Functional annotation of transcriptome profiling differences identified ‘neurological disease’ and ‘CNS devel-
opment related functions’ to be significantly enriched. Several epilepsy-related genes were found differentially
expressed in Wwox KO neurospheres. This study provides the first genotype-phenotype observations as well as
potential mechanistic clues associated with Wwox loss of function in the brain.
1. Introduction
WW domain-containing oxidoreductase (WWOX) is a member of the
short-chain dehydrogenase/reductase (SDR) protein superfamily
(Bednarek et al., 2000). It spans the common fragile site FRA16D in
chromosome region ch16q23.1–23.2 (Bednarek et al., 2000; Ried et al.,
2000).WWOX was originally described by our and other laboratories as
a putative tumor suppressor gene associated tumor progression, and
therapy resistance in multiple cancer types [Reviewed in (Aldaz et al.,
2014; Schrock et al., 2017)]. In more recent studies, WWOX has been
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recognized for its role in a much wider array of human pathologies
including metabolic conditions and central nervous system (CNS) re-
lated syndromes (Aldaz et al., 2014; Chang et al., 2014; Mallaret et al.,
2014).
Findings of Wwox protein expression and distribution in embryonic
and adult murine nervous system highlighted a previously unidentified
role of this protein in the normal development and function of CNS
(Chen et al., 2004). WWOX protein expression was also observed in
various neuronal cell types and regions from the human brain and
cerebellum (Nunez et al., 2006). In 2007 Gribaa et al. described a novel
childhood onset recessive spinocerebellar ataxia, epilepsy and mental
retardation syndrome (cataloged as SCAR12, OMIM: 614322) affecting
children from a large consanguineous family and the defective locus
was mapped to chromosomal region ch16q21-q23 (Gribaa et al., 2007).
Later, in 2014 Mallaret et al. by using whole exome sequencing, iden-
tified WWOX as the culprit defective gene in SCAR12. All probands of
the family described by Gribaa et al. and from an additional con-
sanguineous family carrying homozygous loss of function germline
mutations affecting WWOX suffered from SCAR12 (Mallaret et al.,
2014). Soon thereafter, other groups reported new familial cases of
WWOX homozygous loss of function associated with early infantile
epileptic encephalopathy (EIEE28, OMIM: 616211) also known as
WOREE syndrome (WWOX-related epileptic encephalopathy) (Abdel-
Salam et al., 2014; Ben-Salem et al., 2015; Mignot et al., 2015; Tabarki
et al., 2015; Valduga et al., 2015; Elsaadany et al., 2016). Most of these
familial cases are characterized by homozygous missense, non-sense, or
splice site mutations combined in some cases with deletions ultimately
leading toWWOX loss of function (Mignot et al., 2015). In most cases of
complete loss of WWOX function (e.g. homozygous non-sense muta-
tions) patients presented severe brain structural defects and died within
the first two years of life (Abdel-Salam et al., 2014; Ben-Salem et al.,
2015; Tabarki et al., 2015; Valduga et al., 2015). Consistent with ob-
servations in humans, we reported that Wwox gene deletion leads to
epileptogenesis and early death in mice, where all mice die by ap-
proximately 3 weeks of age (Ludes-Meyers et al., 2009; Mallaret et al.,
2014). This is also in agreement with previous observations in rats
spontaneously mutated at the Wwox locus (Suzuki et al., 2009). No-
tably, while the association of WWOX with CNS pathology is evident
from the multiple human and rodent studies, there is complete lack of
understanding on the pathophysiological mechanisms associated with
WWOX loss of function in brain.
Clinical and experimental studies have demonstrated a clear asso-
ciation between certain types of epilepsy and hippocampal structural
alterations (Schwartzkroin, 1994). Activated microglia and astrogliosis,
are among the most evident deleterious changes affecting hippocampus
function as a consequence of epileptic seizures (Devinsky et al., 2013).
Thus, in this study, using Wwox KO mice we investigated the effects of
Wwox deletion in affecting the abundance of hippocampal GABA-ergic
inhibitory interneurons while investigating effects on inflammatory
markers such as evidence of increased numbers or hypertrophy of glial
fibrillary acidic protein (GFAP) positive astrocytes and ionized calcium
binding adaptor molecule-1 (IBA-1) positive activated microglia. In an
attempt to further understand the molecular effects ofWwox deletion in
hippocampus we also performed RNA sequencing (RNA-Seq) analyses
to compare the transcriptome profile of neural stem cell neurospheres
generated from hippocampi of Wwox KO vs. WT mice.
2. Materialandmethods
2.1. Animal experiments
The protocol for the generation of full Wwox KO mice has been
previously described by our group (Ludes-Meyers et al., 2009; Mallaret
et al., 2014). Briefly, we crossed male Wwox flox/wt mice with female
BK5-Cre+Wwox flox/wt mice (both in mixed 129SV/C57Bl/6 back-
ground). As described by Ramirez et al. Cre recombinase in BK5-Cre
female breeder mice is activated in late oocytes with Cre protein per-
sisting in the embryo leading to constitutive recombination and pro-
ducing full knockout progeny in embryos that are flox/flox (Ramirez
et al., 2004). As controls we used Cre+; Wwox wt/wt littermates (re-
ferred to as Wwox WT elsewhere in the text). Wwox KO mice (2 weeks
old) and age-matched WT controls were used for comparative analysis.
Mice from both sexes approximately 50% male, 50% female were used
for all studies. All animals were bred and kept in a clean, modified-
barrier animal facility, fed regular commercial mouse diet (Harlan Lab.,
Indianapolis, IN) under controlled light (12 L:12D) and temperature
(20–24 °C). All animal research was conducted in facilities accredited
by the Association for Assessment and Accreditation of Laboratory
Animal Care International (AAALAC) at the University of Texas, MD
Anderson Cancer Center, Science Park, following international guide-
lines and all research was approved by the corresponding Institutional
Animal Care and Use Committee (IACUC).
2.2. Animal perfusion and tissue processing
Wwox KO and WT mice were subjected to terminal anesthesia with
isoflurane and trans-cardiac perfusion with 4% paraformaldehyde so-
lution in phosphate buffer (PB). Following this, the brain was carefully
removed from the skull of each animal and post-fixed in 4% paraf-
ormaldehyde for ~16 h at 4 °C. The brain tissues were next treated with
30% sucrose solution in PB until it sank to the bottom and thirty-mi-
crometer thick cryostat sections were cut coronally through the entire
septo-temporal axis of the hippocampus. The sections were collected
serially in 24-well plates filled with PBS. Every 20th section through the
entire hippocampus was then selected fromWwox KO andWT mice and
processed for immunohistochemistry, utilizing various antibodies for
specific cell identification as described below.
2.3. Immunohistochemistry
Several sets of serial sections (every 15th or 20th) through the entire
hippocampus were selected and processed for immunohistochemistry.
The procedures used for immunostaining have been previously de-
scribed (Mishra et al., 2015). Briefly, the sections were etched with PBS
solution containing 20% methanol and 3% hydrogen peroxide for
20min, rinsed thrice in PBS solution, and treated for 30min in PBS
solution containing 0.1% Triton-X 100 and an appropriate serum (10%)
selected on the basis of the species in which the chosen secondary an-
tibody was raised. The primary antibodies comprised anti-PV (P3088;
Sigma-Aldrich), anti-NPY (T-4070; Peninsula Laboratories), anti-IBA-1
(ab5076; Abcam), or anti-GFAP (MAB360; Millipore). After an over-
night incubation with the respective primary antibody solution, sec-
tions were washed thrice in PBS solution and incubated in an appro-
priate secondary antibody solution for 1 h. Biotinylated anti-rabbit (BA-
1000; Vector Lab) and biotinylated anti-mouse (BA-2000; Vector Lab)
were used as secondary antibodies in this study. The sections were
washed thrice in PBS solution and treated with avidin-biotin complex
reagent (PK-6100; Vector Lab) for 1 h. Peroxidase reaction was devel-
oped by using diaminobenzidine (SK-4100; Vector Lab) or vector SG
(SK-4700; Vector Lab) as chromogens, and the sections were mounted
on gelatin-coated slides, dehydrated, cleared, and cover slipped with
Permount.
2.4. Stereological counting of PV+ and NPY+ GABA-ergic Interneurons
Numbers of PV+ or NPY+ interneurons were stereologically
counted for the DG, CA1 and CA3 subfields of the hippocampus. All
counts utilized every 15th or 20th section through the entire septo-
temporal axis of the hippocampus and the optical fractionator method
available in the StereoInvestigator system (Microbrightfield Inc.). The
StereoInvestigator system consisted of a color digital video camera
(Optronics Inc.) interfaced with a Nikon E600 microscope. A detailed
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protocol employed for cell counting using the optical fractionator has
been previous described (Megahed et al., 2014).
2.5. Image analyses of IBA-1+, and GFAP+ immunoreactive structures in
the hippocampus
The areas occupied by IBA-1+ microglia and GFAP+ astrocyte
elements (area fractions) were measured per unit area of the tissue in
the DG, CA1, and CA3 subfields of the hippocampus using Image J, as
detailed in our previous reports (Kodali et al., 2015). In brief, images
from the chosen subfields of the hippocampus were first digitized using
20× lens in a Nikon microscope outfitted with a digital video camera
fixed to a computer and then saved in gray scale as a bitmap file. Using
Image J, a binary image was created from each picture by opting a
threshold that retained all IBA-1+ or GFAP+ immunopositive struc-
tures but no background. The area occupied by the IBA-1+ or GFAP+
structures (i.e., area fraction) in the binary image was quantified by
selecting the Analyze command in the program. Area fraction of IBA-
1+ or GFAP+ immunoreactive elements was calculated separately for
DG, CA1, and CA3 subfields in each animal by using data from all
chosen serial sections.
2.6. Statistical analysis
All the analysis (Wwox KO vs. WT) of the various cell subtypes was
performed using statistical software GraphPad PRISM 7. Student's two-
tailed unpaired t-test was used to compare interneurons numbers and
additional biomarkers. P values of< 0.05 were considered significant.
2.7. Immunoblot analysis
Total protein extracts were prepared from mice hippocampi. Protein
isolation was done using RIPA buffer (50mM HEPES pH 7.4, 150mM
NaCl, 1.5 mM MgCl2, 100mM NaF, 1mM Na3VO4, 1mM EGTA, 1%
Triton X-100, 10% Glycerol) with protease inhibitor cocktail (Roche).
For western blotting, 20 μg of total protein were separated on 10% SDS-
PAGE and transferred to a PVDF membrane. Membranes were blocked
and antibodies were diluted in 5% dry milk/TBST. Primary antibodies
used were: Gad65/67 (Millipore) 1:500 dilution, Wwox (using affinity-
purified anti-WWOX rabbit polyclonal primary antibodies developed in
our laboratory) 1:1000 dilution, HRP conjugated secondary antibodies
were used followed by chemiluminescence (GE Healthcare). Actin was
used as the protein loading control, and it was detected using mono-
clonal anti-actin antibody (Sigma) 1:5000 dilution and HRP conjugated
anti-mouse secondary antibody 1:5000 dilution.
2.8. Generation of neurospheres
The detailed procedure for neural stem cells neurospheres genera-
tion and propagation is described elsewhere (Guo et al., 2012). Briefly,
after euthanizing newborn Wwox KO or WT mice, the brain was col-
lected in 20ml cold HBSS (Hank's Balanced Salt Solution; Invitrogen/
Gibco) in a sterile petri dish. Hippocampus was dissected from the brain
and carefully chopped into smaller pieces. Next, 1 ml Trypsin (0.5%)
(SIGMA) was added, and tissue was incubated for 10–15min at 37 °C to
dissociate the cells. To remove undissipated tissue particles, the cell
suspension was filtered through 70 μm strainer and centrifuged for
5min at 3000 rpm. Cell pellet was suspended in neurobasal medium
(NBM, Thermo Fisher Scientific) containing 20 ng/ml EGF, 10 ng/ml
FGF, 2mM glutamine, antibiotics (100 units/ml penicillin and 100 g/ml
streptomycin), and 0.125 μg/ml fungizone, plated in 6-well plates and
maintained at an atmosphere of 5% CO2 at 37 °C. After 4–7 days of
incubation, neural stem cell formed neurospheres. Subcultures were
prepared every 4–5 days by centrifugation of the neurospheres and
dissociation of cells in trypsin; single-cell suspensions were re-plated in
new culture dishes in fresh medium to obtain new neurospheres.
2.9. RNA-Seq and data analysis
RNA was isolated from neural stem cell neurospheres generated
fromWwox KO andWTmouse hippocampi. To this end, we used TRIzol
reagent (Invitrogen) and the RNeasy mini kit (Qiagen). RNA con-
centration and integrity were measured on an Agilent 2100 Bioanalyzer
(Agilent Technologies). Only RNA samples with RNA integrity values
(RIN) over 8.0 were considered for subsequent analysis. mRNA samples
were processed for directional mRNA-seq library construction using the
ScriptSeq v2 RNA-Seq Library Preparation Kit (Epicentre) according to
the manufacturer's protocol. We performed 76 nt paired-end sequencing
using an Illumina HiSeq3000 platform and obtained ~40 million tags
per sample. The short-sequenced reads were mapped to the mouse re-
ference genome (mm10) by the splice junction aligner TopHat V2.0.10.
We employed several R/Bioconductor packages to calculate gene ex-
pression abundance at the whole-genome level using the aligned re-
cords (BAM files) and to identify differentially expressed genes between
Wwox KO and WT neurospheres. Briefly, to identify differentially ex-
pressed genes between Wwox KO and WT samples we computed fold
change using the EdgeR Bioconductor package based on the normalized
log2 based count per million values (Robinson et al., 2010). Data in-
tegration and visualization of differentially expressed transcripts be-
tween Wwox KO and WT mouse hippocampus derived neurospheres
(log2 fold change [log2 FC] > ±1, p-value< .005, false discovery
rate [FDR] < 0.05) was done with the Multiexperiment Viewer Soft-
ware. Functional enrichment analysis of dysregulated transcripts was
performed using the Ingenuity Pathway Analysis (IPA) database
(http://www.ingenuity.com/index.html).
2.10. Quantitative RT-PCR (qRT-PCR)
Total RNA from neurospheres was isolated as described above.
Hippocampal tissue RNA was isolated using TRIzol reagent (Invitrogen)
following manufacturer's instructions. RNA was quantified, and cDNA
was prepared using RevertAid First Strand cDNA Synthesis Kit
(ThermoFisher, Scientific) following manufacturer's instructions. The
relative expression level for specific genes was determined in triplicate
by qRT-PCR using the SYBR Green-based method. After normalization
to Gapdh expression, the average fold change between Wwox KO and
WT samples was calculated using the 2^-(ΔΔCt) method described
elsewhere (Livak and Schmittgen, 2001). Student's two-tailed unpaired
t-test was used to compare gene expression values, p-values of< 0.05
were considered significant. Primer sequences of the genes tested by
qRT-PCR are shown in Supplementary Table 1.
3. Results
3.1. Wwox KO mice hippocampi exhibit a decrease in PV+ and NPY+
inhibitory interneurons
Inhibitory signals from various subpopulations of GABA-ergic in-
terneurons to principal neurons are critical to maintain the stability of
the neuronal circuitry. The loss of GABA-ergic interneurons alters the
balance of excitatory and inhibitory synaptic transmission inducing
hippocampal hyperexcitability potentially leading to epileptiform ac-
tivity and affecting cognitive functions (Liu et al., 2014). We first ex-
amined the distribution of fast-spiking parvalbumin expressing (PV+)
GABA-ergic interneurons in the DG (dentate gyrus) and the CA1 and
CA3 (cornu ammonis) hippocampal subfields of Wwox KO (n=7) and
WT (n= 7) mice. To this end, we used immunohistochemical staining
of coronal brain sections with an antibody against PV followed by
stereological quantification (Fig. 1). In the DG region of Wwox WT
mice, PV+ interneurons were clearly observed (Fig. 1 A1). In contrast,
the DG region of Wwox KO mice displayed a significant reduction in
number of PV+ interneurons. Some hippocampal areas in Wwox KO
mice showed a complete absence of such cells (Fig. 1 B1). A
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significantly low number of PV+ interneurons in Wwox KO mice was
also evident in the CA1 and CA3 subfields (Figs. 1 A2-A3, B2-B3, and
C2-C3). Stereological quantification indicated that Wwox KO mice
displayed astatistically significant reduction in the total number of PV
+ interneurons in the DG region (p < .005, Fig. 1 C1) and CA1 sub-
field (p < .05, Figs. 1 C2), in comparison to control mice. The overall
reduction of PV+ interneurons in Wwox KO mice amounted to 44%
when the hippocampus was taken in its entirety (p < .005, Fig. 1 D).
Fig. 1. | Wwox KO mice hippocampi exhibit a decrease in PV+ interneurons.
Panels (A) and (B) show representative microphotographs illustrating the distribution of PV+ interneurons in DG (dentate gyrus) and the CA1 and CA3 (cornu
ammonis) subfields of the hippocampus of 2 wk. old Wwox WT(A1-A3) and Wwox KO(B1-B3) mice. The insets show magnified images of single interneuron from
each subfield (marked with arrows). A paucity of PV+ neuronal cell bodies and processes can be appreciated in the various hippocampal regions of Wwox KO mice
(B1-B3)versus comparable regions from Wwox WT control counterparts. Bar charts (C1-C3 and D) show stereological results comparing the number of PV+ in-
terneurons in DG (C1), CA1 subfield (C2), CA3 subfield (C3), and the entire hippocampus (D). Bar graphs represent the average values of Wwox WT (n=7) and
Wwox KO (n=7) mice as indicated. Error bars represent± SEM, *p < .05; **p < .005, two tailed unpaired Student's t-test. DH, dentate hilus; GCL, granule cell
layer.
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We also analyzed the abundance of a second subpopulation of
GABA-ergic interneurons, the NPY+ interneurons. The neuropeptide Y
released from NPY+ GABA-ergic interneurons is an endogenous an-
ticonvulsant neurotransmitter that modulates the activity of excitatory
neurons (Vezzani et al., 1999). We calculated the abundance of these
interneurons in hippocampal subfields of Wwox KO (n=6) and WT
(n= 6) mice by immunostaining of coronal brain sections using a NPY
antibody followed by stereological analysis (Fig. 2). In the DG region of
Fig. 2. | Wwox KO mice hippocampi exhibit a decrease in NPY+ interneurons.
Panels (A) and (B) show representative images illustrating the distribution of NPY+ interneurons in DG and the CA1 and CA3 subfields of the hippocampus of 2 wk.
old Wwox WT(A1-A3) and Wwox KO(B1-B3) mice. A significant reduction in the number of NPY+ cells is apparent in the DG subfield of a Wwox KO mouse (B1) in
comparison to the same region from a Wwox WT counterpart (A1). Bar charts (C1-C3 and D) compare the average number of NPY+ interneurons in DG (C1), CA1
subfield (C2), CA3 subfield (C2), and the entire hippocampus (D) from Wwox WT (n=6) and Wwox KO (n=6) mice as indicated. Error bars represent± SEM,
*p < .05, two tailed unpaired Student's t-test. DH, dentate hilus; GCL, granule cell layer.
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WT mice, significant numbers of NPY+ cells were clearly observed,
especially in the dentate hilus region (Fig. 2 A1), in contrast the DG
region ofWwox KOmice displayed a 30% reduction in the total number
of NPY+ interneurons when compared to control WT mice (p < .05)
(Figs. 2 B1 and C1). However, the CA1 and CA3 subfields, did not ex-
hibit any obvious difference in the number of NPY+ interneurons be-
tween Wwox KO and WT mice (Figs. 2 A2-A3, B2-B3, and C2-C3).
Number of NPY+ interneurons in the entire hippocampus is shown in
Fig. 2 D.
In summary, Wwox KO mice exhibit significant reductions in the
abundance of both PV+ and NPY+ GABA-ergic interneurons in the
various hippocampal subfields.
3.2. Wwox KO mice hippocampi display evidence of microgliosis
Pathogenic insults to the CNS generate a non-specific reactive re-
sponse affecting glial cells termed gliosis (Burda and Sofroniew, 2014).
Gliosis involves hypertrophy and activation of different types of glial
cells including microglia and astrocytes and is often the result of a re-
active inflammatory response (Devinsky et al., 2013).Microgliosis (ac-
tivation of microglia) is commonly the first observed stage of gliosis.
We investigated microglia activation by immunohistochemical staining
for ionized calcium binding adaptor molecule-1 (IBA-1), also known as
allograft inflammatory factor expressed in activated macrophages, both
in WT (n=6) and Wwox KO (n= 6) mice (Fig. 3). The area fraction
(AF) occupied by IBA-1+ cells was marginally higher in the DG region
(Figs. 3 A1, B1 and C1), however the CA1 and CA3 subfields displayed a
significant increase (p < .05) in the AF occupied by IBA-1+ structures
inWwox KO mice and when the hippocampus (p < .005) is considered
in its entirety (Figs. 3 A2-A3, B2-B3, C2-C3, and D). Importantly, IBA-
1+ cells in CA1 and CA3 subfields of Wwox KO were less ramified,
displayed shorter and thicker processes and larger soma, characteristic
of activated microglia (see Figs. 3 B2-B3 insets).
3.3. Wwox KO mice hippocampi display evidence of astrogliosis and
increased inflammatory cytokines expression
We also investigated for evidence of astrogliosis (activation of as-
trocytes) by means of glial fibrillary acidic protein (GFAP) im-
munostaining and area fraction analysis using Image J. We observed a
significant increase in the area occupied by astrocytic elements in
hippocampi from Wwox KO mice (n=8) in comparison to WT mice
(n=6) (Fig. 4). Astrocytes displayed hypertrophy as well as hyper-
plasia in the hippocampus of Wwox KO mice. As a consequence, in
Wwox KO mice, the area fraction (AF) occupied by GFAP+ soma and
processes of astrocytes in the CA1 and CA3 subfields displayed a very
significant increase of 36% and 53%, respectively (p < .05 Figs. 4 A2-
A3, B2-B3, and C2-C3), whereas in the DG region the increment was
marginal (Figs. 4 A1, B1 and C1). When the hippocampus was taken in
its entirety, the overall increase in GFAP+ structures was 30% inWwox
KO mice (p < .05, Fig. 4 D).
Since we observed evidence of neuroinflammation in the form of
activated microglia and reactive astrocytes in Wwox KO mice, we fur-
ther investigated the expression of well known neuroinflammatory cy-
tokines Il6 and Tnf-a in hippocampal tissue by qRT-PCR. We ob-
served>1.5 fold upregulation of both cytokines (Il6 significant at
p < .05) inWwox KO (n=4) mice in comparison toWwox WT (n= 4)
mice (Fig. 4 E).
3.4. Wwox KO mice hippocampi show reduced GAD65/67 protein
expression
GABA, the major inhibitory neurotransmitter in the mammalian
brain, is synthesized by two glutamate decarboxylase isoforms, GAD65
and GAD67. GAD65/67 protein expression was shown to accurately
reflect levels of GABA synthesis and abundance (Lindefors, 1993),
therefore decreased expression of these proteins would also indicate
lower GABA levels. As observed in Fig. 5A, Western blot analysis of
hippocampal protein extracts obtained from Wwox KO mice (n=5)
compared with WT mice (n=5) revealed significantly lower levels of
GAD65/67 protein expression. Quantitative densitometry analysis de-
monstrates a significant reduction in GAD65/67 expression in Wwox
KO mice (p < .05, Fig. 5B).
3.5. Comparative transcriptome profiling of hippocampus derived neural
stem cell neurospheres
To gain some insight on the molecular effects of Wwox deletion, we
performed RNA-Seq analyses for comparing the gene expression pro-
files of neural stem cell (NSC) neurospheres generated from hippocampi
ofWwox KO andWT mice. Neurospheres are an excellent model system
for the study of NSCs in vitro (Guo et al., 2012). Our aim for performing
transcriptome profiling on RNA isolated from neurospheres is to de-
termine the effect of Wwox deletion in comparable pure populations of
progenitor cells capable of differentiating into diverse CNS cell subtypes
while avoiding the confounding factors of tissue heterogeneity that
would arise from analyzing total hippocampus RNA.
Unsupervised analysis of RNA-Seq data demonstrates clear segre-
gation of Wwox KO and WT control mice samples (Fig. 6 A). Com-
parative transcriptome analysis allowed us to identify 283 differentially
expressed genes between both groups (log2 FC > ±1, p value< .005,
FDR < 0.05) (Fig. 6 A). Out of the 283 differentially expressedgenes,
184 transcripts were up-regulated and 99 were down-regulated in
Wwox KO samples when compared with control samples (Supplemen-
tary Table 2). Next, we performed functional enrichment analysis using
the Ingenuity Pathway Analysis (IPA) platform. Interestingly, based on
the behavior of dysregulated transcripts in the Wwox KO group, IPA
identified ‘neurological disease’ among the top diseases (p-value range:
7.10E-05 - 7.74E-20) and ‘nervous system development and function’ as
the top physiological biofunction (p-value range: 6.82E-05 - 9.06E-26).
Within the neurological disease subgroup, ‘epilepsy’, ‘seizure disorder’,
‘cognitive impairment’ and ‘neurodegeneration’ showed a positive Z
score value implying that these disorders are positively associated with
Wwox deletion (Fig. 6 B).
Next, from the list of 283 differentially expressed genes we identi-
fied a group of transcripts on the basis of either one of the following two
criteria: (i) the transcript falls within a panel of 172 genes implicated in
epilepsy as reported by Rim et al.; this dataset is based on an extensive
literature review and the Online Mendelian Inheritance in Man (OMIM)
database search (Rim et al., 2018), or (ii) the gene is identified by IPA
as a member of the set of dysregulated genes that identify with epilepsy
and/or seizure related disorders as per functional enrichment analyses.
Table 1 shows the list of 16 genes that were short-listed based on the
described criteria. Also shown in Table 1 is the function and potential
relevance of these genes with epilepsy supported by available literature
(Table 1). All these RNA-Seq observations were validated by qRT-PCR
on RNA isolated from neurospheres (data not shown).
To further investigate whether any of the gene expression changes
observed affecting progenitor cells in vitro would be observable in vivo,
we analyzed expression of all genes on RNA isolated from hippocampi
freshly dissected from a separate set of Wwox KO (n=4) and WT
(n= 4) mice. From this in vitro – in vivo comparison the most striking
changes behaving in the same direction in both conditions was the very
significant downregulation in expression of the NMDA receptor Grin2c,
glutamate receptor Grm3, and voltage-gated potassium channel Kcna2
genes in Wwox KO mice when compared to WT controls (Figs. 6 C and
D).
4. Discussion
This study provides the first pathophysiological evidence on the
effects of Wwox loss of function in the brain. Importantly, we observed
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that Wwox deletion leads to a significant reduction in the overall
number of PV+ and NPY+ GABA-ergic inhibitory interneurons in
mouse hippocampus. Additionally, we also detected evidence of active
neuroinflammation and gliosis in the brains of Wwox KO mice.
Loss of GABA-ergic inhibitory function have been observed in
several human epileptiform disorders and experimental animal models
of epilepsy and is postulated to be a susceptibility factor or trigger of
some genetic forms of human epilepsy (Powell, 2013). Genetic muta-
tions resulting in functional changes in GABA receptors including the
selective loss, or functional impairment, of GABA-ergic interneurons
Fig. 3. | Wwox KO mice hippocampi exhibit increase in IBA-1+ cells indicating microglia activation.
Panels (A) and (B) display representative images illustrating the distribution and morphology of IBA-1+ microglial cells in the DG and CA1 and CA3 subfields of the
hippocampus of 2 wk. old Wwox WT(A1-A3) and Wwox KO(B1-B3) mice. A significant increase in the area fraction (AF) occupied by IBA-1+ structures in CA1 and
CA3 subfield as well as entire hippocampus can be observed inWwox KO mouse. Bar charts (C1-C3 and D) compared the average AF occupied by IBA-1+ astrocytes
in DG (C1), CA1 subfield (C2), CA3 subfield (C3), and the entire hippocampus (D) from Wwox WT (n=6) and Wwox KO (n=6) mice as indicated. Error bars
represent± SEM, *p < .05, two tailed unpaired Student's t-test. DH, dentate hilus.
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may disrupt the regulation of local excitatory circuits, resulting in hy-
perexcitability of neuronal networks thus contributing to epileptogen-
esis (Williams and Battaglia, 2013). Among the most vulnerable inter-
neurons in human and animal models of epilepsy are those expressing
PV. We observed significantly lower numbers of PV+ interneurons in
the hippocampi of Wwox KO mice and it was described that reduced
number of PV+ interneurons can lead to hippocampal hyperexcit-
ability (Schwaller et al., 2004). Furthermore, studies in epilepsy models
have shown that loss of PV+ interneurons in the DG greatly reduces the
inhibition of dentate granule cells thus contributing to epileptogenesis
(Kobayashi and Buckmaster, 2003). Our analysis also shows that the
overall number of NPY+ interneurons is reduced in the DG region of
Wwox KO mice. Like PV+ interneurons, NPY+ interneurons also play
an important role in regulating the activity of hippocampal circuitry.
The NPY released from these interneurons modulates the activity of
excitatory neurons by consistently hyperpolarizing and reducing their
spike frequency (Fu and van den Pol, 2007) and by inhibiting the
glutamate release to principal hippocampal neurons (Colmers and
Bleakman, 1994). NPY is an endogenous anti-seizure compound, which
is evident from its upregulation in conditions such as status epilepticus,
and reduced epileptiform activity in neurons upon NPY treatment
(Vezzani et al., 1999). It has also been shown that adult Npy null mice
show increased sensitivity and poor outcomes after chemically induced
seizures (Erickson et al., 1996). Thus, the substantial loss of PV+ and
NPY+ interneurons in Wwox null mice may induce hippocampal hy-
perexcitability and be, at least in part, responsible for the epileptic
phenotype observed in these mice. Furthermore, substantial loss of PV
+ interneurons in the hippocampus can considerably impair theta
rhythm involved in cognitive function (Klausberger et al., 2005). Re-
duced NPY can also impair learning and memory function (Zaben and
Gray, 2013). In this context, learning and memory deficits in conditions
such as autism may be linked at least partially to alterations affecting
WWOX.
Also, we observed a reduction in levels of the two glutamate dec-
arboxylase (GAD) isoforms Gad65 and Gad67 in Wwox null hippo-
campi. GAD65 and GAD67 are the principal enzymes that synthesize
GABA from glutamate in the mammalian brain (Lindefors, 1993). Ex-
pression of GADs has been reported to accurately reflect levels of GABA
synthesis and activity (Lindefors, 1993). For instance, selective elim-
ination of Gad65 has been shown to elicit spontaneous seizures that
results in increased mortality in Gad65 −/− mice (Kash et al., 1997).
Thus, decreased expression of Gad65/67 in the hippocampi of Wwox
null mice goes hand in hand with the described reduction in numbers of
GABA-ergic interneurons and suggest the existence of a hippocampal
hyperexcitable state.
Clinical and experimental observations have provided strong
evidence that inflammatory processes within the brain might constitute
a crucial mechanism in the pathophysiology of seizures and epilepsy
(Vezzani et al., 2011). We observed that Wwox null mice display signs
of neuroinflammation as suggested by the increased detection of IBA-
1+ cells (i.e., activated microglia) and GFAP+ astrocytes as well as
increased expression of inflammatory cytokines Tnf-a and Il6. TNF-a
and IL6 are the most extensively studied prototypical cytokines in the
brain which are first expressed in activated microglia and astrocytes as
consequence of pathogenic insults such as trauma, infection or neuro-
degenerative diseases (Glass et al., 2010). Notably, pro-inflammatory
molecules, microgliosis, astrogliosis, and other indicators of in-
flammation have been found in the resected hippocampi of patients
with different forms of epilepsy and also in rodent models of epilepsy
(Shapiro et al., 2008; Vezzani et al., 2011). The finding of biomarkers of
neuroinflammation in Wwox KO mice brains supports the idea that
inflammation might play a role in Wwox related epilepsy. However,
further investigation is needed to gather additional mechanistic insight
on what is cause or consequence upon Wwox loss of function.
We also performed RNA-Seq to profile the transcriptome wide ef-
fects of Wwox deletion in neural progenitor cells. Interestingly, the
comparative analysis of transcriptional profiles from NSC derived from
Wwox KO vs. WT mice reveled significant differences reflecting altera-
tions that identify with CNS related disorders and in particular ‘cogni-
tive impairment’, ‘seizures’, ‘seizure disorders’ and ‘epilepsy’ among the
most prevalent functional annotations. Importantly, this is in close
agreement with human familial syndromes associated with WWOX
mutations and loss of function. At the specific gene level, we observed a
significant down-regulation of Glutamate Ionotropic Receptor NMDA
Subunit 2C (Grin2c), Glutamate Metabotropic Receptor 3 (Grm3), and
Potassium Voltage-Gated Channel Subfamily A Member 2 (Kcna2) inWwox
KO NSCs as well as in whole hippocampal tissue.
GRIN2C is a subunit of the glutamate-gated ion channels N-methyl-
D-aspartate receptors (NMDAR). NMDARs are crucial for neuronal
communication and are capable of converting specific patterns of
neuronal activity into long-term changes in synapse structure and
function. Dysfunction of NMDARs including GRIN2A and GRIN2B has
been reported in various neurological and psychiatric disorders
(Paoletti et al., 2013). Interestingly, GRIN2A loss of function mutations,
either through nonsense-mediated mRNA decay or premature termi-
nation resulting in the synthesis of dysfunctional protein, have been
associated with focal epilepsy and speech disorder with or without
mental retardation (Endele et al., 2010). In line, GRIN2B loss of func-
tion mutations have been associated with mental retardation and
autism (Endele et al., 2010), while in cases of early infantile epileptic
encephalopathy both loss and gain of GRIN2B function mutations have
been reported (Platzer et al., 2017). Therefore, it is logical to speculate
Fig. 4. | Wwox KO mice hippocampi exhibit increase in GFAP+ astroglial activation as evidence of increase gliosis.
Panels (A) and (B) display representative microphotographs illustrating the distribution and morphology of GFAP+ astrocytes in the various hippocampal subfields
of 2 wk. oldWwox WT(A1-A3) andWwox KOmice (B1-B3). A considerable increase in the AF occupied by GFAP+ structures in the CA1 and CA3 subfields as well as
the entire hippocampus is observed in Wwox KO mice. Bar graphs (C1-C3 and D) compare the average AF occupied by GFAP+ astrocytes in DG (C1), CA1 subfield
(C2), CA3 subfield (C3), and the entire hippocampus (D) ofWwox WT (n=6) andWwox KO (n=8) as indicated. Error bars represent± SEM, *p < .05, two tailed
unpaired Student's t-test. (E) Expression of Tnf-a and Il6 in Wwox KO mice hippocampi (n=4). Y axis in the graph represents relative linear FC values with respect
(w.r.t) to Wwox WT mice hippocampi (n=4); error bars represent± SEM, *p value< .05, two tailed unpaired Student's t-test.
Fig. 5. | Wwox KO mice hippocampi show reduced
expression of Gad65/67 isoforms.
(A) Immunoblot of glutamic acid decarboxylase
(Gad) protein isoforms in Wwox WT and Wwox KO
mice hippocampi tissue lysates as indicated. (B) Bar
graphs representing the average densitometry im-
munoblot bands representing Gad65/67 protein ex-
pression, normalized to Actin loading control, in
Wwox WT (n=5) and Wwox KO (n=5) mice. Error
bars represent± SEM, *p value< .05, two tailed
unpaired Student's t-test.
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that Grin2C downregulation may also lead to abnormal NMDAR re-
ceptor function by altering receptor subunit composition and indeed
this has been speculated to be a key variable and potential cause of
epileptogenesis (Paoletti et al., 2013).
KCNA2 is a member of voltage-gated potassium channel family that
are expressed in the CNS and plays an important role in neuronal ex-
citability and neurotransmitter release (Lai and Jan, 2006). Many de
novo missense and loss- or gain-of-function mutations in KCNA2 have
been associated with severe early-onset epileptic encephalopathy,
ataxia, cognitive and language impairment, and behavioral disorders
(Masnada et al., 2017). In most of the cases, the onset of epilepsy oc-
curred within the first to second year of life, while the loss- and gain-of-
function subgroups show the earliest, often neonatal onset. Mice har-
boring Kcna2 mutations are also reported to display chronic motor
Fig. 6. | Gene expression profile of Wwox KO vs. WT mice hippocampal neural stem cells neurospheres.
(A) Unsupervised clustering and heatmap for the 283 differentially expressed genes with log2 FC > ±1, p-value< .005, FDR < 0.05 comparing Wwox KO and
Wwox WT mice hippocampi derived neurospheres. Red or green colors indicate differentially up or downregulated genes, respectively. The mean signals were
background corrected and transformed to the log2 scale. (B) Bar graph representing functional annotations indicating enrichment for cognitive impairment, epilepsy
and seizure related disorders as consequence of dysregulated gene expression in NSCs fromWwox KO mice with Z scores> 1 and p-value< .00001, numbers on the
top of each bar represents the number of genes enriched in that specific category as per IPA analysis. (C, D) Relative expression of Grin2C, Grm3, and Kcna2 as per
RNA-Seq data, Wwox KO mice (n=2) relative to Wwox WT (n=3) (C), and as per qRT-PCR on RNA obtained from Wwox KO (n= 4) relative to Wwox WT (n= 4)
hippocampi (D). Y axis in the RNA-Seq data graph (C) represents relative log2 FC values while in hippocampi graph (D) it represents relative linear FC values, with
respect to Wwox WT mice; error bars represent± SEM, ***p < .0001, two tailed unpaired Student's t-test.
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incoordination, ataxia, increased seizure, and premature death due to
loss of Kcna2 function (Xie et al., 2010). Early-onset epilepsy and pre-
mature death observed in KCNA2 mutant humans and mice are similar
phenotypes to those observed in our Wwox KO mouse model which
makes Kcna2 an important candidate for future studies.
We also observed a decrease in Grm3 expression in Wwox KO mice.
Grm3 is a G protein-coupled metabotropic glutamate receptor and acts
in part as an inhibitory autoreceptor, influencing synaptic plasticity
(Niswender and Conn, 2010). A role of this receptor has been associated
with the pathophysiology and therapy of many neuropsychiatric dis-
orders including bipolar disorders, Alzheimer's disease, anxiety dis-
orders and in particular schizophrenia (Moreno et al., 2009). A poten-
tial role for metabotropic glutamate receptors has also been suggested
in epilepsy (Aronica et al., 2000).
In conclusion, our observations may explain, at least in part, what is
occurring in the brains of patients affected by WWOX loss of function
pathologies. One notable observation regarding WWOX related epi-
leptic disorders is that cases characterized by complete WWOX loss of
function mutations, as in early infantile epileptic encephalopathies
(EIEE28, OMIM #616211) also described as WOREE syndrome, are
always accompanied by mental retardation, usually display severe
brain structural abnormalities, and patients die within the first two
years of life (Abdel-Salam et al., 2014; Ben-Salem et al., 2015; Mignot
et al., 2015; Tabarki et al., 2015; Valduga et al., 2015), thus displaying
a very short lifespan similar to our mouse Wwox KO model where all
mice die by approximately 3 weeks of age (Ludes-Meyers et al., 2009).
However, in other cases presented with missense mutations that lead to
expression of a defective WWOX protein (i.e. hypomorphs) premature
death was not reported (Mallaret et al., 2014; Mignot et al., 2015). In
addition to epilepsy and seizure disorders, alterations affecting WWOX
have also been associated with other neuropathologies including Alz-
heimer's disease (Sze et al., 2004; Wang et al., 2012),autism (Bartnik
et al., 2012; Leppa et al., 2016) and other intellectual disabilities
(Alkhateeb et al., 2016) and interestingly the WWOX locus was also
found associated to infant brain volumes (Xia et al., 2017).
Importantly, in recent studies, Wwox has been identified as one of a
very limited set of long neural genes characterized by harboring re-
current double strand break clusters and undergoing genomic re-
arrangements in primary neural stem/progenitor cells as part of critical
processes likely associated with the specialized behavior of brain cells
(Wei et al., 2016). Strinkingly, most ofthese genes have been associated
to CNS pathologies and cancer (Wei et al., 2016). These observations
further stress the critical relevance of WWOX in normal CNS develop-
ment.
The observations reported here fill a gap of knowledge providing
clues to start understanding the consequences and potential mechan-
isms at play in the CNS of patients affected by WWOX loss of function
conditions. Although these human pathologies are rare, it stimulates to
further pursue studies aimed at understanding the clearly important
role of WWOX in normal CNS development and function.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nbd.2018.09.026.
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